Following the success of previous events, SMi’s 5th annual conference on Orphan Drugs returns to London this Autumn. Registration is now live for this unmissable CPD-certified event.
Visit the website for more information.
The orphan drug industry has seen a dramatic increase in pharmacologic cures for rare diseases and has revolutionized medicine, paving the way for other drug candidates to enter this space. Simultaneously, the market is expected to grow to reach an estimated $191 billion by 2019*. With such innovation and growth witnessed in the field, now is the time to discuss strategies to overcome the many challenges within the orphan drug development landscape.
With a focus on the latest regulatory developments and strategies for the best route to market, the conference will explore how payers, pharmaceutical, biotech and patient organizations are preparing to participate in and leverage the growing orphan drugs and rare diseases industry. Featured speakers include MHRA, Chiesi Pharma, National Institute for Health and Care Excellence, Alexion Pharma, Mereo BioPharma and more.
5th Orphan Drugs Conference:
To register, please click here.